Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Nat Immunol. 2012 Mar 4;13(4):379-86. doi: 10.1038/ni.2238.
Tolerance to endotoxins that is triggered by prior exposure to Toll-like receptor (TLR) ligands provides a mechanism with which to dampen inflammatory cytokines. The receptor-interacting protein RIP140 interacts with the transcription factor NF-κB to regulate the expression of genes encoding proinflammatory cytokines. Here we found lipopolysaccharide stimulation of kinase Syk-mediated tyrosine phosphorylation of RIP140 and interaction of the NF-κB subunit RelA with RIP140. These events resulted in more recruitment of the E3 ligase SCF to tyrosine-phosphorylated RIP140, which degraded RIP140 to inactivate genes encoding inflammatory cytokines. Macrophages expressing nondegradable RIP140 were resistant to the establishment of endotoxin tolerance for specific 'tolerizable' genes. Our results identify RelA as an adaptor with which SCF fine tunes NF-κB target genes by targeting the coactivator RIP140 and show an unexpected role for RIP140 degradation in resolving inflammation and endotoxin tolerance.
先前暴露于 Toll 样受体 (TLR) 配体所引发的内毒素耐受为抑制炎症细胞因子提供了一种机制。受体相互作用蛋白 RIP140 与转录因子 NF-κB 相互作用,调节编码促炎细胞因子的基因的表达。在这里,我们发现脂多糖刺激激酶 Syk 介导的 RIP140 酪氨酸磷酸化,以及 NF-κB 亚基 RelA 与 RIP140 的相互作用。这些事件导致更多的 E3 连接酶 SCF 募集到酪氨酸磷酸化的 RIP140 上,从而降解 RIP140 以失活编码炎症细胞因子的基因。表达不可降解 RIP140 的巨噬细胞对特定“可耐受”基因的内毒素耐受的建立具有抗性。我们的研究结果确定 RelA 作为衔接蛋白,通过靶向共激活因子 RIP140,精细调节 NF-κB 靶基因,并显示 RIP140 降解在解决炎症和内毒素耐受中的意外作用。